Cardiovascular & Metabolic Disorders
Updates to the US Preventive Services Task Force's recommendations on obesity screening in children and adolescents focus on intensive behavioral interventions.
Widely promoted as healthy, coconut oil can increase LDL cholesterol levels similar to other saturated fats.
For patients with type 2 diabetes, visit-to-visit variability in systolic blood pressure may function as an independent predictor for cardiovascular events.
The most effective approaches to CVD self-management were tailored to individual patient needs and incorporated a multidisciplinary approach.
Researchers presented data from the ODYSSEY DM Insulin and Dyslipidemia trials at ADA 2017.
Despite multiple measures and goals to reduce US maternal mortality rates, the latest data suggest the United States is far behind the rest of the world in maternal health care.
According to Journal of the American Heart Association, pregnant women with chronic hypertension using antihypertensive agents reduces the risk of hypertension without added risk to the fetus.
Patients with metabolic syndrome experienced an increase in Unified Parkinson's Disease Rating Scale (UPDRS) scores.
The role of cholesterol in Parkinson's disease is not well understood.
Two studies examined the effects of naltrexone/bupropion on weight loss, glycemic parameters, and cardiovascular risks in patients with type 2 diabetes.
Patients with type 2 diabetes taking statins after insulin initiation had better glycemic control, but their risk for mortality was higher compared with patients who did not take statins.
Riser patterns in patients' BP resulting from orthostatic hypotension has been linked to increased rates of mortality and major adverse cardiac and cerebrovascular events.
Low-Carbohydrate vs Low-fat Diet Success In Patients With Prediabetes Differs According to Fasting Insulin LevelsJune 13, 2017
Fasting plasma glucose, insulin, and insulin sensitivity levels were measured to determine their prognostic value as markers for long-term weight loss.
Researchers conducted a subgroup analysis of the SPRINT clinical trial to determine whether intensive blood pressure treatment outcomes were similar in patients with prediabetes vs normal fasting blood glucose levels.
Canagliflozin reduced levels of cardiovascular stress biomarkers N-terminal pro-B type natriuretic peptide and high sensitivity troponin I.
Flow mediated dilation changes improved in patients who received dapagliflozin.
Sitagliptin improved glucose excursion and lowered triglyceride levels in men with prediabetes who were also overweight.
Interventions seeking to counteract antipsychotic-induced weight gain and cardiometabolic disturbances have had limited success.
Neonates did not differ in terms of birthweight, fat mass, body fat percentage, and sum of skinfolds, regardless of treatment.
Patients with cardiovascular disease and both type 2 diabetes and chronic kidney disease had the highest risk for mortality.
Resveratrol supplements were fount to activate the SIRT1 gene, which delays aging and the development of various diseases.
Patients with type 2 diabetes had lower rates of heart failure hospitalization, MACE, and all-cause mortality when treated with dapagliflozin.
Vitamin K antagonists and low-molecular weight heparin were associated with the lowest risks of adverse maternal and fetal outcomes.
Individuals with low BMI are not at an increased risk for Alzheimer disease.
Long-term use of anabolic-androgenic steroids increases risks for decreased left ventricular diastolic function and increased coronary plaque volume.
Women at high risk for preeclampsia should take low-dose aspirin as a preventive therapy.
Age significantly affected the association between hot flash status and flow-mediated dilation, particularly in younger women.
The fewer menstrual cycles women had over a lifetime placed them at greater risk for incident heart failure.
A 37-year-old woman presented to the emergency department with recurrent dizziness following her recent pregnancy.
Cardiometabolic Comorbidities, Hospitalizations, and Costs Associated With Schizophrenia and Bipolar DisorderMay 18, 2017
People with schizophrenia or bipolar disorder experience twice the rate of diabetes and metabolic syndrome compared to the general population.
Endocrinology Advisor Articles
- Semaglutide Improved Beta-Cell Function and Glycemic Control in Type 2 Diabetes
- Blood Glucose Self-Monitoring in Type 2 Diabetes Does Not Benefit Glycemic Control
- Elagolix Relieves Short-Term Menstrual Pain, Dysmenorrhea in Endometriosis
- Improving Glycemic Control in T2D With Text Message Intervention
- The Handoff: Your Week in Endocrinology News - 6/23/17
- Reduced Cardiovascular Events in Type 2 Diabetes Treated With Dapagliflozin
- Prolonged Delayed Eating Linked to Weight Gain, Increased Respiratory Quotient
- Canagliflozin Reduces Cardiovascular Stress In Older Patients With Type 2 Diabetes
- GLP-1 Analog Counteracts Antipsychotic-Induced Glucose Intolerance, Weight Gain
- Diabetic Retinopathy Caused by Sleep Apnea in T2D
- USPSTF Updates Recommendations for Screening Obesity in Children and Adolescents
- Exercise Protocol Improves Outcomes in T2D
- Interspersed Upper Body Activity With Sedentary Time Improves Glucose, Insulin
- AHA Advisory: Replace Saturated Fat to Reduce CVD By 30%
- Type 2 Diabetes Death and CV Events Predicted by Systolic Blood Pressure Variability